Biosyngen Announces FDA Fast Track Designation for BST02 in Treatment of Liver Cancer
SINGAPORE, Feb. 1, 2024 /PRNewswire/ -- Biosyngen is proud to announce that its latest groundbreaking product, BST02, has been granted...
Treatment
Adding Immunotherapy to Local Treatment Delays Liver Cancer Progression
Adding the immune checkpoint inhibitor Imfinzi (durvalumab) and the VEGF inhibitor Avastin (bevacizumab) to transarterial chemoembolization (TACE) led to improved...
The impact of COVID-19 on the diagnosis and treatment of HCC: analysis of a nationwide registry for advanced liver diseases (REAL)
Study design and participantsIn this study, we retrieved data of patients initially diagnosed with HCC between January 2018 and December...
Liver Cancer in Dogs: Symptoms, Diagnosis, and Treatment
Your dog’s liver plays an important role in their health, from filtering toxins from their blood to helping with digestion....
FDA approves first-of-its-kind new ‘bubble’ treatment for liver cancer
Sign up for our free Health Check email to receive exclusive analysis on the week in healthGet our free Health...
Blood clot in the leg: Treatment, aftercare, and prevention
When a blood clot develops in the leg, doctors refer to it as deep vein thrombosis (DVT). Deep veins carry...
